NEW Methylation Screening Array Service

The Infinium Methylation Screening Array (MSA) is the first, high-throughput, scalable human DNA methylation service fully dedicated to epidemiology and population study. It offers comprehensive and tailored coverage of common disease biomarkers, epigenetic clocks, and functional epigenomics markers, including cell-type specific methylation and SNPs.

The MSA provides robust, highly reproducible data comparable to 100X sequencing depth.

Comprehensive Epidemiological Screening Assay:

• Deeper understanding of epidemiological risks: Transitioning from standard Genome-Wide Association Study (GWAS) to epigenomics (EWAS) - will enhance insights through DNA Methylation.
• New Biomarker Content: Over 270,000 methylation sites tailored for common diseases with nearly half of them being new compared to the existing array
• Scalability for population studies: This high-throughput assay, which accommodates 48 samples per array, increases the efficiency of screening initiatives.
• End-to-end services: Include bisulfite conversion, array hybridization, array scan, and data quality control